Tag - STIM

Developments

Neuronetics gets FDA breakthrough device designation for NeuroStar

Neuronetics (NASDQ:STIM) received FDA breakthrough device designation for its NeuroStar Advanced Therapy System for the treatment of bipolar depression. Neurostar is a transcranial magnetic stimulation device that...

March 6, 2020

Markets

Analysts slash Neuronetics PTs but maintain buy ratings

Analysts for Canaccord Genuity and BTIG slashed their prices targets for Neuronetics (NASDAQ:STIM) but maintained their “buy” ratings after the company reported that third quarter results missed consensus estimates...

November 6, 2019

Developments

Neuronetics receives Japanese reimbursement for NeuroStar’s TMS Therapy

Transcranial magnetic stimulation (TMS) pioneer, Neuronetics (NASDQ:STIM), received reimbursement approval from Japan’s Central Social Insurance Medical Council for its NeuroStar Advanced Therapy for the treatment...

March 28, 2019

Tag - STIM

Neuronetics gets FDA breakthrough device designation for NeuroStar

Analysts slash Neuronetics PTs but maintain buy ratings

Neuronetics receives Japanese reimbursement for NeuroStar’s TMS Therapy

General

More